sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Warning-sign checks

CMV retinitis: when to get help

Go through these in order and stop at the first one that applies. If you are reading this for someone else, answer for them.

  1. 1

    Is any of this happening now?

    Call 911
    Other emergency signs, for anyone
    • Someone who is struggling to breathe, gasping, choking, or cannot get words out
    • Someone who has chest pain, tightness or pressure lasting more than a few minutes
    • Someone who has sudden weakness or drooping on one side of the face or body, slurred speech, or sudden confusion
    • Someone who is unconscious, or cannot be woken
    • Someone who is bleeding heavily and it will not stop with firm pressure
    • Someone who has had a seizure that will not stop, or does not wake up afterwards
    • Someone who has lips or skin that look pale, blue, grey or blotchy
    • Someone who you believe has taken an overdose or swallowed something poisonous
  2. 2

    Is any of this happening?

    Be seen today

    Do not wait for the next routine appointment if new floaters, flashes, blurred vision, blind spots, or other visual changes develop.

  3. 3

    Does any of this apply?

    Book an appointment

    Frequent follow-up is part of treatment.

    The ophthalmologist needs to confirm that the edges of the infected area have stopped advancing and check for retinal tears, detachment, or inflammation.

    Routine appointments are appropriate when vision is stable and the care team has provided a monitoring schedule.

The article also says

NIH guidance recommends an eye examination when treatment begins, again after about two weeks, and then approximately monthly while anti-CMV treatment continues.

The schedule may be more frequent for infection near the macula or optic nerve, or when symptoms change.

After immune recovery, examinations are often continued at longer intervals, such as every three months.

Maintenance therapy may sometimes be stopped in a person with HIV after the retinal lesions have been inactive and the CD4 count has remained above 100 cells per cubic millimeter for at least three to six months because of effective antiretroviral therapy.

This decision should be made jointly by the ophthalmologist and HIV specialist.

Treatment may need to restart if immune function declines.

For transplant recipients and other people without HIV, the duration of treatment depends on the cause and expected length of immune suppression.

Their transplant, cancer, or immune-disorder team should coordinate any changes to immune-suppressing medicine.

Every sign above is quoted from the sofidex article on CMV retinitis. If you are not sure, err upward — it is always reasonable to be checked.